Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

TIL Q4 2020 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena

TILInstil Bio, Inc.

$60M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$17M

Net Income

-$17M

EPS (Diluted)

$-0.49

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$62M

Stock-Based Comp.

$415,000

Balance Sheet

Total Assets

$319M

Total Liabilities

$27M

Stockholders' Equity

$292M

Cash & Equivalents

$242M

← FY 2020 All Quarters Q1 2021 →